已收盘 07-18 16:00:00 美东时间
-0.160
-1.08%
JMP Securities analyst Jason Butler reiterates Rapport Therapeutics (NASDAQ:RAPP) with a Market Outperform and maintains $28 price target.
07-08 22:14
Gainers Theriva Biologics (AMEX:TOVX) stock moved upwards by 47.4% to $0.72 du...
06-03 05:05
Rapport Therapeutics' Phase 2a trial of RAP-219 for refractory focal epilepsy is fully enrolled and set to report top-line results in September 2025. The company hosted its first Investor and Analyst Day to discuss clinical pipeline updates, including RAP-219's progress. RAP-219, an AMPA receptor negative allosteric modulator, targets TARPγ8 for neuroanatomical specificity. The trial's interim data show favorable tolerability, with all adverse ev...
06-02 18:45
Rapport Therapeutics, a clinical-stage biotech company focused on small molecule precision medicines for neurological and psychiatric disorders, announced that its management will participate in two upcoming investor conferences: the Jefferies Global Healthcare Conference in New York City on June 4, 2025, and the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 9, 2025. Live and archived webcasts of the fireside chats will ...
05-27 11:00
Rapport Therapeutics (NASDAQ:RAPP) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.76) by 10.53 percent.
05-08 19:15
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117013356914663424.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持FTC Solar(FTCI)"买入"评级,目标价从1.5美元升至5美元</p> <p>• 摩根士丹利:维持艾伯维(ABBV)"超配"评级,目标价从239美元升至241美
04-10 09:00
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Pacira BioSciences(PCRX)"买入"评级,目标价从48美元升至65美元</p> <p>• 瑞穗:上调Amylyx Pharmaceuticals(AM
04-09 08:50
Rapport Therapeutics press release (NASDAQ:RAPP): Q4 Net Loss for the fourth quarter of 2024 was $20.0 million, as compared to $13.5 million for the prior year period. The Company ended the fourth qua...
03-11 21:41
云安全公司Okta绩后暴涨24%!华尔街分析师集体上调其目标价;Castellum大涨21%,获得美国海军重大合同>>
03-05 19:34
Rapport Therapeutics, Inc. ( ($RAPP) ) has shared an announcement. On March 3, ...
03-03 20:49